Raloxifene is known to raise the risk of blood clots. But in a 2006 US clinical trial comparing the drug with tamoxifen for breast cancer prevention, ...
... called ellagitannin, which gets broken down in the body to urolithin B. It acts like our aromatase-blocking drugs (think tamoxifen or raloxifene). ...
